Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Regulatory
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
The KIT mutation assay developed for clinical use in the Mayo Molecular
Hematopathology Laboratory detects the KIT mutation responsible
for Asp816Val. The technique used is allele-specific oligonucleotide
polymerase chain reaction (ASO-PCR) with fragment analysis on an
ABI3100 genetic analyzer. Briefly, DNA is extracted from whole bone
marrow or blood and PCR is used to amplify across the mutation site in
2 separate tubes; 1 contains a reverse primer complementary to the
unmutated sequence and the other contains a reverse primer
complementary to the mutated sequence. Each of these reverse primers
is labeled with a fluorescent tag and both tubes contain an identical,
nonlabeled forward primer. Both primer sets amplify a 200 bp fragment
that differs only at the mutation site. The unmutated fragment should be
amplified in all samples. Samples negative for KIT Asp816Val will not
have an amplified fragment in the mutated reaction tube. Positive
samples will have amplified fragments in both the unmutated and mutated
tubes. The test gives a qualitative (positive or negative) result only, as
the end point PCR used is not reliable for quantification. (Unpublished
Mayo method)